Literature DB >> 18321576

Costimulatory strength influences the differential effects of transforming growth factor beta1 for the generation of CD8+ regulatory T cells.

Timothy M Fan1, David M Kranz, Richard A Flavell, Edward J Roy.   

Abstract

Transforming growth factor beta1 (TGFbeta1) is a pleiotropic cytokine, capable of exerting diverse biologic effects. Despite its central role in multiple immune activities, the molecular signals responsible for shaping TGFbeta1's immunologic properties remain poorly elucidated. We report that costimulatory strength acts as a molecular switch, which influences the differential effects of TGFbeta1 on the effector and regulatory development of naïve CD8+ lymphocytes. At low costimulation, TGFbeta1 inhibits proliferation of CD8+ lymphocytes and cytokine secretion, but at high costimulation the response to TGFbeta1 is quite different. High costimulation combined with TGFbeta1 generates CD8+CD25+ T lymphocytes which maintain robust proliferative and survival capacity in the presence of low IL-2 concentrations. Furthermore, under these conditions, a subpopulation of CD8+ T lymphocytes is generated that express Foxp3, secrete IL-10, and inhibit naïve T lymphocyte proliferation via a contact-dependent mechanism. The adoptive transfer of these CD8+CD25+Foxp3+ T cells into mice inoculated intravenously with B16F10 melanoma appears to accelerate tumor progression as reflected by an increase in the number of pulmonary metastatic tumor foci. These findings indicate that costimulatory strength may act as a molecular switch in the generation of CD8+ T cells which possess a regulatory phenotype and the capacity to reduce antitumor immune responses within tumor-bearing mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18321576     DOI: 10.1016/j.molimm.2008.01.019

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  8 in total

1.  Protective roles of quercetin in acute myocardial ischemia and reperfusion injury in rats.

Authors:  Hong-Bo Jin; Yong-Bin Yang; Ying-Li Song; Yong-chun Zhang; Yu-Rong Li
Journal:  Mol Biol Rep       Date:  2012-10-08       Impact factor: 2.316

2.  HCV+ hepatocytes induce human regulatory CD4+ T cells through the production of TGF-beta.

Authors:  Caroline H T Hall; Rachel Kassel; Robert S Tacke; Young S Hahn
Journal:  PLoS One       Date:  2010-08-13       Impact factor: 3.240

Review 3.  Prevention of allograft rejection by amplification of Foxp3(+)CD4(+)CD25(+) regulatory T cells.

Authors:  Guliang Xia; Malathi Shah; Xunrong Luo
Journal:  Transl Res       Date:  2008-12-25       Impact factor: 7.012

4.  TGF-beta modulates the functionality of tumor-infiltrating CD8+ T cells through effects on TCR signaling and Spred1 expression.

Authors:  Maria Giovanna di Bari; M E Christine Lutsiak; Shinji Takai; Sven Mostböck; Benedetto Farsaci; Roshanak Tolouei Semnani; Lalage M Wakefield; Jeffrey Schlom; Helen Sabzevari
Journal:  Cancer Immunol Immunother       Date:  2009-03-25       Impact factor: 6.968

Review 5.  Cancer immunotherapy: the role regulatory T cells play and what can be done to overcome their inhibitory effects.

Authors:  Ulf Petrausch; Christian H Poehlein; Shawn M Jensen; Chris Twitty; James A Thompson; Ilka Assmann; Sachin Puri; Michael G LaCelle; Tarsem Moudgil; Levi Maston; Kevin Friedman; Sarah Church; Elisa Cardenas; Daniel P Haley; Edwin B Walker; Emmanuel Akporiaye; Andrew D Weinberg; Sidney Rosenheim; Todd S Crocenzi; Hong-Ming Hu; Brendan D Curti; Walter J Urba; Bernard A Fox
Journal:  Curr Mol Med       Date:  2009-08       Impact factor: 2.222

6.  Cutting Edge: Tumor-specific CD8+ T cells infiltrating prostatic tumors are induced to become suppressor cells.

Authors:  Kimberly A Shafer-Weaver; Michael J Anderson; Katherine Stagliano; Anatoli Malyguine; Norman M Greenberg; Arthur A Hurwitz
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

Review 7.  Treating autoimmune disease by targeting CD8(+) T suppressor cells.

Authors:  Christine Konya; Jorg J Goronzy; Cornelia M Weyand
Journal:  Expert Opin Biol Ther       Date:  2009-08       Impact factor: 4.388

8.  Effect of Ligusticum wallichii aqueous extract on oxidative injury and immunity activity in myocardial ischemic reperfusion rats.

Authors:  Qiao Zengyong; Ma Jiangwei; Liu Huajin
Journal:  Int J Mol Sci       Date:  2011-03-18       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.